The caninized anti-canine PD-1 monoclonal antibody in canine oral malignant melanoma: Efficacy and exploratory biomarker analysis
Masaya Igase, Kenji Hagimori, Sakuya Inanaga, Hiroyuki Mizoguchi, Kazuhito ITAMOTO, Masashi Sakurai, Tomoki Motegi, Hiroka Yamamoto, M. Kato, Toshinori Shiga, Toshihiro Tsukui, Tetsuya Kobayashi, Takuya Mizuno
This study evaluates a caninized anti-PD-1 antibody in canine oral malignant melanoma, finding associations between baseline inflammatory markers and MSI status with treatment outcomes.
bioRxiv · Aug 26, 2025 · PreprintCancer Biology